Chiang Contextualizes the Optimal Use of Lurbinectedin in SCLC Management

Season 11 Episode 7  ·  Aug 29, 2024, 08:40 PM

Headliner
Share
Subscribe

Dr Chiang discusses the use of lurbinectedin in small cell lung cancer and tips for managing toxicities associated with this agent.

Share
Subscribe
Next
Salgia Summarizes the Benefits of Tepotinib in MET Exon 14–Mutated NSCLC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air